檢測認證人脈交流通訊錄
阿扎那韋雜質(zhì),伊曲康唑雜質(zhì) aitraconazole,鹽酸倍他洛爾雜質(zhì)
- 阿扎那韋雜質(zhì)對照品
Atazanavir-d5,
Des-N-(methoxycarbonyl)-L-tert-leucine Atazanavir Trihydrochloride,
Des-N-(methoxycarbonyl)-L-tert-leucine Atazanavir-d5 Trihydrochloride,
去-N-(甲氧基羰基)-L-tert-亮氨酸 Bis-Boc 阿扎那韋:Des-N-(methoxycarbonyl)-L-tert-leucine Bis-Boc Atazanavir , Des-N-(methoxycarbonyl)-L-tert-leucine Bis-Boc Atazanavir-d5,
阿扎那韋 Atazanavir
(LGC)
伊曲康唑雜質(zhì)
伊曲康唑雜質(zhì)A 4-[4-[4-(4-Methoxyphenyl)piperazin-1-yl]phenyl]-2-[(1RS)-1-methylpropyl]-2,4-dihydro-3H-1,2,4-triazol-3-one
伊曲康唑雜質(zhì)B Itraconazole Impurity B
伊曲康唑雜質(zhì)C Itraconazole Impurity C
伊曲康唑雜質(zhì)D Itraconazole Impurity D
伊曲康唑雜質(zhì)E Itraconazole Impurity E
伊曲康唑雜質(zhì)F Itraconazole Impurity F
伊曲康唑雜質(zhì)G Itraconazole Impurity G
伊曲康唑系統(tǒng)穩(wěn)定性 Itraconazole System Suitability Mixture (25 mg)
伊曲康唑?qū)φ掌?
鹽酸倍他洛爾雜質(zhì), betaxolol hydrochloride
鹽酸倍他洛爾雜質(zhì)A,Imp. A (EP) as Hydrochloride: (2RS)-
1-(4-Ethylphenoxy)-3-[(1-methylethyl)amino]-propan-2-ol Hydrochloride
鹽酸倍他洛爾雜質(zhì) B
Imp. B (EP): (2RS)-1-[4-(2-Hydroxyethyl)phenoxy]-3-[(1-methylethyl)amino]propan-2-ol
鹽酸倍他洛爾雜質(zhì) C
Imp. C (EP): 2-[[4-[2-(Cyclopropylmethoxy)-ethyl]phenoxy]methyl]oxirane
鹽酸倍他洛爾雜質(zhì) D
Imp. D (EP): 4-[2-(Cyclopropylmethoxy)ethyl]phenol
鹽酸倍他洛爾雜質(zhì) E
Imp. E (EP) as Hydrochloride: (2RS)-1-[4-(2-Butoxyethyl)phenoxy]-3-[(1-methylethyl)amino]propan-2-ol
Hydrochloride
鹽酸倍他洛爾對照品